Newomics

company

About

Newomics commercializes innovative and integrative platforms and solutions for personalized healthcare.

  • Berkeley,California,United States
  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$3.92M
Industries
Biotechnology,Health Care,Wellness
Founded date
Jan 1, 2018
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
Newomics Inc

Newomics is an early stage biotechnology company that commercializes innovative and integrative platforms and solutions for personalized healthcare. Its proprietary technology is based on silicon-microfluidic-chip for liquid chromatography-mass spectrometry (LC-MS) and offers unprecedented robustness, sensitivity, specificity, and throughput for analyzing molecules from minute amounts of biospecimens such as blood and urine.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$15.72M
Newomics has raised a total of $15.72M in funding over 2 rounds. Their latest funding was raised on Dec 1, 2020 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 1, 2020 Series B $7.90M 4 MSA Capital Detail
Oct 27, 2020 Series Unknown $3.92M Detail
Aug 9, 2018 Series A $3.90M 2 Berkeley Catalyst Fund (BCF) Detail

Investors

Number of Lead Investors
Number of Investors
2
4
Newomics is funded by 4 investors. MSA Capital and Berkeley Catalyst Fund (BCF) are the most recent investors.
Investor Name Lead Investor Funding Round
MSA Capital Yes Series B
Berkeley Catalyst Fund (BCF) Series B
LDV Partners Series B
Photon Fund Series B

Employee Profiles

Number of Employee Profiles
2
Newomics has 2 current employee profiles, including Executive Frank Slovenec
Executive
Executive